The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 30, 2022

Filed:

Aug. 11, 2016
Applicant:

Trana Discovery, Inc., Cary, NC (US);

Inventors:

Steven E. Peterson, Cary, NC (US);

Samuel P. Yenne, Raleigh, NC (US);

Joseph Christopher Ellis, Westfield, IN (US);

Richard H. Guenther, Cary, NC (US);

Assignee:

TRANA DISCOVERY, INC., Cary, NC (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6837 (2018.01); C12N 15/115 (2010.01); C12Q 1/18 (2006.01); C12N 15/11 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6837 (2013.01); C12N 15/11 (2013.01); C12N 15/115 (2013.01); C12Q 1/18 (2013.01); C12N 2310/3517 (2013.01); C12N 2320/12 (2013.01); C12N 2503/02 (2013.01);
Abstract

Methods are disclosed for identifying antibacterial compounds which inhibit propagation of selected spectrum bacteria, which bacteria use specific tRNA to code for Ala, Met, Ser, or Leu that other bacteria do not use. In one embodiment, the selected spectrum bacteria use GCA to code for Ala, whereas other bacteria use a different codon to code for alanine. The methods involve determining whether putative inhibitors promote or inhibit complex formation between the tRNA and a bacterial ribosome, or between the tRNA and an aminoacyl synthetase. Compounds which promote or inhibit complex formation can disrupt protein production, which bacteria need to propagate. The identified antibacterial compounds can selectively inhibit bacterial propagation. By limiting their effects to the selected spectrum bacteria, these compounds can treat or prevent specific bacterial infections without disrupting the normal bacterial flora, the patients' microbiome, or causing antibacterial resistance.


Find Patent Forward Citations

Loading…